Weighing the odds: A new toolkit helps assess COVID-19 vaccine benefits vs risks | NEW PAPER
The rapid rollout of COVID-19 vaccines was essential, but questions and concerns arose about rare side effects, such as thrombosis with thrombocytopenia syndrome (TTS) linked to the Vaxzevria (AstraZeneca) vaccine. Assessing whether the benefits of vaccination still outweigh these potential risks is complex. In our latest work published in The…